Prior Authorization of Iron, Parenteral - Pharmacy Services
Customize your policy alerts
Sign up for all Pennsylvania Insurance Department policy alerts
Know when Pennsylvania Insurance Department releases new policies or updates existing guidance.
Monitor payer policy activity
Establishes prior authorization requirements and medical necessity review criteria for parenteral iron prescriptions for providers enrolled in Pennsylvania Medical Assistance fee-for-service.
Medical necessity guidelines for Iron, Parenteral were updated to specify that prescriptions exceeding Department-established quantity limits require prior authorization.
Coverage Criteria for Parenteral Iron
Non-preferred agent medical necessity
Covered when ALL of the following are met
Reviewer applies evidence of therapeutic failure, contraindication, or intolerance to preferred parenteral irons per clinical review guidelines
Quantity limit exceedance review
Covered when criteria in Quantity Limits chapter are met
Reviewer applies Quantity Limits Chapter guidance when evaluating exceedance requests
This bulletin applies to all licensed pharmacies and prescribers enrolled in the Medical Assistance (MA) Program and providing services in the fee‑for‑service delivery system. Providers rendering services in the MA managed care delivery system should direct questions about Iron, Parenteral to the appropriate managed care organization rather than to the Department’s fee‑for‑service prior authorization processes.
Prior authorization personnel will apply the clinical guidelines in Section B when reviewing requests for Iron, Parenteral. If the guidelines are not met, the request will be referred to a physician reviewer for a medical necessity determination. The physician reviewer may approve the request when, in their professional judgment, the services are medically necessary; otherwise the request may be denied at the discretion of the physician reviewer.
Coding and Quantity Limits
Provider Actions and Prior Authorization
Prior authorization required for non-preferred products and quantity-limit exceedances
Prior authorization is required for any non-preferred Iron, Parenteral and for any Iron, Parenteral prescription with a prescribed quantity that exceeds the Department-established quantity limits. See the Preferred Drug List for preferred products and the Department Quantity Limits list for numeric limits.
- Non-preferred Iron, Parenteral prescriptions must be prior authorized.
- Prescriptions exceeding Department quantity limits must be prior authorized.
Step/failure evidence required for non-preferred agents
Reviewers require documentation showing history of therapeutic failure, contraindication, or intolerance to preferred Irons, Parenteral when evaluating prior authorization requests for non-preferred agents.
- Evidence of prior therapeutic failure to preferred agents.
- Documentation of contraindication or intolerance to preferred agents.
Required documentation and handbook procedures for prior authorization
Providers must follow the procedures in SECTION I of the Prior Authorization of Pharmaceutical Services Handbook and submit supporting documentation as specified in the clinical review guidelines; quantity-limit exceedance requests must include the information required by the Quantity Limits chapter.
- Follow SECTION I procedures in the Prior Authorization of Pharmaceutical Services Handbook (per 55 Pa. Code § 1101.67(a)).
- Include documentation showing therapeutic failure, contraindication, or intolerance when requesting PA for non-preferred agents.
- For quantity-limit exceedances, include the information specified in the Quantity Limits Chapter.
Denial risk if clinical review guidelines are not met
Requests that do not meet the clinical review guidelines in Section B will be referred to a physician reviewer and may be denied if the physician reviewer does not determine the services are medically necessary.
- If Section B guidelines are met, the reviewer will prior authorize the prescription.
- If not met, the request is escalated to a physician reviewer whose professional judgment determines approval or denial.
Key Definitions
Background and Purpose
This bulletin updates medical necessity guidelines and prior authorization procedures for parenteral iron products used in Medicaid (Medical Assistance) fee‑for‑service. The Department will apply the clinical review guidelines in Section B and the Department’s Quantity Limits when evaluating prior authorization requests. As a result of the update, prescriptions for non‑preferred parenteral iron products and prescriptions that exceed Department‑established quantity limits now explicitly require prior authorization, and reviewers will consider documented therapeutic failure, contraindication, or intolerance to preferred agents when making determinations. Providers must follow the procedures in the Prior Authorization of Pharmaceutical Services Handbook (SECTION I) and submit supporting documentation requested in the Quantity Limits chapter as applicable.
Initial Therapy Prior Authorization Criteria
Initial therapy PA
Initial prior authorization considerations
Per Section B clinical review guidelines; physician reviewer may approve by professional judgment if criteria not met
Step Therapy and Failure Documentation
| Requirement | Details |
|---|---|
| Documented history of therapeutic failure, contraindication, or intolerance to preferred agents | |
| Prescriptions for a non-preferred Iron, Parenteral will be prior authorized only when the beneficiary has a documented history of therapeutic failure, contraindication, or intolerance to the preferred Irons, Parenteral. |
Department Quantity Limits
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.